Effect of ivermectin on COVID-19: A multicenter double-blind randomized controlled clinical trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of ivermectin on COVID-19: A multicenter double-blind randomized controlled clinical trial
Authors
Keywords
clinical trial, cough, COVID-19, dyspnea, ivermectin, lymphopenia
Journal
CLINICAL THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-07
DOI
10.1016/j.clinthera.2021.04.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arguments in favor of remdesivir for treating SARS-CoV-2 infections
- (2020) Wen-Chien Ko et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection
- (2020) Adam Bernheim et al. RADIOLOGY
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
- (2020) Hao Xu et al. International Journal of Oral Science
- Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency
- (2020) Carlos Chaccour et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Lymphopenia in COVID‐19: Therapeutic Opportunities
- (2020) Nazanin Fathi et al. CELL BIOLOGY INTERNATIONAL
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
- (2020) Zhaohai Zheng et al. JOURNAL OF INFECTION
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
- (2020) Emanuele Rizzo NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelets in Coronavirus Disease 2019
- (2020) Julie Brogaard Larsen et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Ecotoxic response of nematodes to ivermectin, a potential anti-COVID-19 drug treatment
- (2020) Naceur Essid et al. MARINE POLLUTION BULLETIN
- Association Between Hypoxemia and Mortality in Patients With COVID-19
- (2020) Jiang Xie et al. MAYO CLINIC PROCEEDINGS
- Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic
- (2020) Sarah Lim et al. MAYO CLINIC PROCEEDINGS
- Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
- (2020) Ian Huang et al. Journal of Intensive Care
- Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19
- (2020) Celal Satici et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial
- (2020) Julio Vallejos et al. Trials
- Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?
- (2018) Rebecca E. Chandler AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started